Advances in the diagnosis and treatment of pediatric acute lymphoblastic leukemia

H Inaba, CH Pui - Journal of clinical medicine, 2021 - mdpi.com
The outcomes of pediatric acute lymphoblastic leukemia (ALL) have improved remarkably
during the last five decades. Such improvements were made possible by the incorporation of …

Clustered miRNAs and their role in biological functions and diseases

SP Kabekkodu, V Shukla, VK Varghese… - Biological …, 2018 - Wiley Online Library
MicroRNAs (miRNAs) are endogenous, small non‐coding RNAs known to regulate
expression of protein‐coding genes. A large proportion of miRNAs are highly conserved …

Precision medicine in acute lymphoblastic leukemia

CH Pui - Frontiers of medicine, 2020 - Springer
The cure rate of childhood acute lymphoblastic leukemia (ALL) has exceeded 90% in some
contemporary clinical trials. However, the dose intensity of conventional chemotherapy has …

Cancer hallmarks and microRNAs: the therapeutic connection

K Van Roosbroeck, GA Calin - Advances in cancer research, 2017 - Elsevier
Human cancers are characterized by a number of hallmarks, including sustained
proliferative signaling, evasion of growth suppressors, activated invasion and metastasis …

[HTML][HTML] Inhibition of monocarboxyate transporter 1 by AZD3965 as a novel therapeutic approach for diffuse large B-cell lymphoma and Burkitt lymphoma

RA Noble, N Bell, H Blair, A Sikka, H Thomas… - …, 2017 - ncbi.nlm.nih.gov
Inhibition of monocarboxylate transporter 1 has been proposed as a therapeutic approach to
perturb lactate shuttling in tumor cells that lack monocarboxylate transporter 4. We examined …

MicroRNA in leukemia: Tumor suppressors and oncogenes with prognostic potential

R Mardani, MH Jafari Najaf Abadi… - Journal of cellular …, 2019 - Wiley Online Library
Leukemia is known as a progressive malignant disease, which destroys the blood‐forming
organs and results in adverse effects on the proliferation and development of leukocytes and …

BCL-XL is crucial for progression through the adenoma-to-carcinoma sequence of colorectal cancer

P Ramesh, TRM Lannagan, R Jackstadt… - Cell Death & …, 2021 - nature.com
Evasion of apoptosis is a hallmark of cancer, which is frequently mediated by upregulation of
the antiapoptotic BCL-2 family proteins. In colorectal cancer (CRC), previous work has …

Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia in adults

K Saleh, A Fernandez, F Pasquier - Cancers, 2022 - mdpi.com
Simple Summary Outcome of patients with Philadelphia-chromosome positive acute
lymphoblastic leukemia (Ph+ ALL) dramatically improved during the past 20 years with the …

Targeting mitochondrial apoptosis to overcome treatment resistance in cancer

NYL Ngoi, C Choong, J Lee, G Bellot, ALA Wong… - Cancers, 2020 - mdpi.com
Deregulated cellular apoptosis is a hallmark of cancer and chemotherapy resistance. The B-
cell lymphoma 2 (BCL-2) protein family members are sentinel molecules that regulate the …

Specific delivery of miRNA for high efficient inhibition of prostate cancer by RNA nanotechnology

DW Binzel, Y Shu, H Li, M Sun, Q Zhang, D Shu… - Molecular Therapy, 2016 - cell.com
Both siRNA and miRNA can serve as powerful gene-silencing reagents but their specific
delivery to cancer cells in vivo without collateral damage to healthy cells remains …